Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
INJECTABLE COLD ENERGY THERAPY FOR THE MANAGEMENT OF CHRONIC PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE
NCT06700109 · View on ClinicalTrials.gov ↗
Study Summary
The goal of this clinical trial is to evaluate the effectiveness of Neural Ice for pain management associated with knee osteoarthritis in adults aged 22-80 years. Participants will attend study visits and complete subject diaries. Participants will be followed for 6 months after study procedure.
Conditions Studied
Interventions
- DEVICE Neural Ice
- DRUG Triamcinolone acetate
Study Locations (15)
Oklahoma
- Clinical Investigations, LLC — Edmond
- NextStage Clinical Research The Orthopedic Center — Tulsa
Texas
- NextStage Clinical Research All-American Orthopedic & Sports Medicine Institute — Houston
- UT San Antonio — San Antonio
California
- Marin Health — Larkspur
District of Columbia
- Centers for Advanced Orthopedics — Washington D.C.
Florida
- The Orthopaedic Institute — Gainesville
Georgia
- Emory University — Johns Creek
Illinois
- Insight Hospital and Medical Center Chicago — Chicago
Kansas
- NextStage Clinical Research Advanced Orthopaedic Associates — Wichita
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 263 participants |
| Start Date | 2024-11-19 |
| Est. Completion | 2027-02-01 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06700109
The ClinicalTrials.gov registry entry for NCT06700109 describes a study currently listed as active not recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 263 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brixton Biosciences, which has 1 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Osteoarthritis (OA) of the Knee appearing as the primary indexed condition, and to 2 interventions — of which Neural Ice is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT06700109 reports 15 study locations spanning 13 distinct geographic areas — top geographies include Oklahoma, Texas, California. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT06700109 about?
NCT06700109 is a clinical study titled "INJECTABLE COLD ENERGY THERAPY FOR THE MANAGEMENT OF CHRONIC PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE". The goal of this clinical trial is to evaluate the effectiveness of Neural Ice for pain management associated with knee osteoarthritis in adults aged 22-80 years. Participants will attend study visits and complete subject diaries. Participants will be followed for 6 months after study procedure.
What is the current status of trial NCT06700109?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 263 participants. The study started on 2024-11-19. Estimated completion is 2027-02-01.
What conditions does trial NCT06700109 study?
This clinical trial studies the following conditions: Osteoarthritis (OA) of the Knee. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT06700109?
The interventions under investigation include: Neural Ice (DEVICE), Triamcinolone acetate (DRUG). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT06700109?
This trial is sponsored by Brixton Biosciences, which has 1 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT06700109 being conducted?
This trial has 15 study locations across California, District of Columbia, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.